NM_022081.6:c.*1613C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022081.6(HPS4):​c.*1613C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.887 in 152,260 control chromosomes in the GnomAD database, including 60,489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60468 hom., cov: 32)
Exomes 𝑓: 1.0 ( 21 hom. )

Consequence

HPS4
NM_022081.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.09

Publications

6 publications found
Variant links:
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
HPS4 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BP6
Variant 22-26451620-G-T is Benign according to our data. Variant chr22-26451620-G-T is described in ClinVar as Benign. ClinVar VariationId is 340965.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.945 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022081.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS4
NM_022081.6
MANE Select
c.*1613C>A
3_prime_UTR
Exon 14 of 14NP_071364.4
HPS4
NM_001349900.2
c.*1613C>A
3_prime_UTR
Exon 15 of 15NP_001336829.1
HPS4
NM_001349901.1
c.*1613C>A
3_prime_UTR
Exon 15 of 15NP_001336830.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS4
ENST00000398145.7
TSL:1 MANE Select
c.*1613C>A
3_prime_UTR
Exon 14 of 14ENSP00000381213.2
HPS4
ENST00000422379.3
TSL:5
c.*1613C>A
3_prime_UTR
Exon 15 of 15ENSP00000415081.3
HPS4
ENST00000473782.2
TSL:2
c.*1613C>A
3_prime_UTR
Exon 15 of 15ENSP00000514223.1

Frequencies

GnomAD3 genomes
AF:
0.887
AC:
134981
AN:
152100
Hom.:
60452
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.779
Gnomad AMI
AF:
0.886
Gnomad AMR
AF:
0.802
Gnomad ASJ
AF:
0.980
Gnomad EAS
AF:
0.852
Gnomad SAS
AF:
0.925
Gnomad FIN
AF:
0.991
Gnomad MID
AF:
0.934
Gnomad NFE
AF:
0.951
Gnomad OTH
AF:
0.897
GnomAD4 exome
AF:
1.00
AC:
42
AN:
42
Hom.:
21
Cov.:
0
AF XY:
1.00
AC XY:
34
AN XY:
34
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
1.00
AC:
2
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
1.00
AC:
34
AN:
34
Other (OTH)
AF:
1.00
AC:
4
AN:
4

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.887
AC:
135048
AN:
152218
Hom.:
60468
Cov.:
32
AF XY:
0.886
AC XY:
65974
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.779
AC:
32318
AN:
41502
American (AMR)
AF:
0.801
AC:
12250
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.980
AC:
3403
AN:
3472
East Asian (EAS)
AF:
0.852
AC:
4409
AN:
5176
South Asian (SAS)
AF:
0.925
AC:
4464
AN:
4824
European-Finnish (FIN)
AF:
0.991
AC:
10510
AN:
10610
Middle Eastern (MID)
AF:
0.932
AC:
274
AN:
294
European-Non Finnish (NFE)
AF:
0.951
AC:
64722
AN:
68028
Other (OTH)
AF:
0.894
AC:
1890
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
701
1402
2104
2805
3506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.924
Hom.:
81961
Bravo
AF:
0.867
Asia WGS
AF:
0.859
AC:
2989
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hermansky-Pudlak syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.45
DANN
Benign
0.59
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3752589; hg19: chr22-26847586; API